Naproxcinod Completed Phase 1 Trials for Renal Failure Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00674856A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function